Jun 15, 2022 / 09:40PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
So let's get underway. Good afternoon, everybody. Welcome to Goldman Sachs Healthcare Conference Wednesday afternoon. My name is Chris Shibutani. I'm a member of the Goldman Sachs research team, pharmaceuticals and biotech. We are very excited to welcome Alkermes once again to join us. And I am very pleased and excited to be in-person, seated opposite Richard. Once again, Richard it's fantastic to see you.
Richard F. Pops - Alkermes plc - Chairman & CEO
Likewise.
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Thank you for joining us. You're joined at this event by our Chief Financial Officer. Iain is out there, he's waving. And then, of course, Sandy, who everybody knows, keeps everybody on top of things as always, and the voice of reason and keeps everybody on schedule. So much appreciated, Sandy.
Alkermes Plc at Goldman Sachs Global Healthcare Conference Transcript
Jun 16, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers